The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Roche; Sotio
ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.
 
Domenica Lorusso
Honoraria - AstraZeneca; Clovis Oncology; genmab; Immunogen; Merck; Roche; tesaro
Consulting or Advisory Role - PharmaMar
Speakers' Bureau - AstraZeneca; Clovis Oncology; pharmamar; tesaro
Research Funding - Clovis Oncology (Inst); Merck (Inst); PharmaMar (Inst); tesaro (Inst)
Expert Testimony - Clovis Oncology
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche; TESARO
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Robert L. Coleman
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Leslie M. Randall
Honoraria - BluPrint Oncology
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; GOG Foundation; Immunogen; Merck; Mersana; Novocure; Tesaro
Speakers' Bureau - AstraZeneca; Merck; Tesaro
Research Funding - Aivita Biomedical (Inst); Akeso Biopharma (Inst); AstraZeneca (Inst); GEICO (Inst); Genentech/Roche (Inst); Merck (Inst); On Target Laboratories (Inst); Pfizer (Inst); Tesaro (Inst)
 
Linda R. Duska
Consulting or Advisory Role - CUE Biopharma; Genentech/Roche; Inovio Pharmaceuticals; Merck; Morphotek; Tesaro
Research Funding - Abbvie (Inst); Aduro Biotech (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Cerulean Pharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Leap Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Millennium (Inst); Morab (Inst); Morphotek (Inst); Novartis (Inst); Pfizer (Inst); Syndax (Inst); Syndax (Inst); Tesaro (Inst)
 
Yang Xiang
No Relationships to Disclose
 
Kosei Hasegawa
Honoraria - AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; MSD K.K
Consulting or Advisory Role - Kaken Pharmaceutical; MSD K.K
Research Funding - Daiichi Sankyo; Ono Pharmaceutical
 
Angelica Nogueira Rodrigues
Honoraria - AstraZeneca; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; MSD; Roche
 
David Cibula
No Relationships to Disclose
 
Mansoor Raza Mirza
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; ECS PROGASTRIN; GlaxoSmithKline; LEK; Novartis; Roche/Genentech; TESARO
Research Funding - Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Immunogen; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Melissa Christiaens
No Relationships to Disclose
 
Cagatay Taskiran
No Relationships to Disclose
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; ImmunoGen; MSD; Roche; Takeda; Tesaro
Research Funding - Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD; Roche
 
Jacob Korach
Consulting or Advisory Role - AstraZeneca; MSD Oncology
 
Christian Marth
Consulting or Advisory Role - Amgen; AstraZeneca; MSD; Novartis; PharmaMar; Roche; Tesaro
Research Funding - Roche
 
Stephen Michael Keefe
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Martina Puglisi
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)